Illumina Protein Prep can measure 9500 unique human protein targets, offering new insights into protein biology to fuel novel discovery for treatment of disease Following early access program, customers commend scale, high consistency, and easy sample to insights workflow Launch follows Illumina’s announcement of agreement to acquire SomaLogic SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced the […]
New addition to PacBio Compatible program enables scientists to connect genetic variation with gene regulation in a single assay, advancing research in rare disease and cancer MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced that EpiCypher, a recognized leader in epigenetics tools, has joined the […]
Durham, NC – EpiCypher®, a pioneer in epigenomic research and technology, announces the launch of CUTANA® Fiber-seq, a groundbreaking multiomic genomics platform that captures both genomic and epigenomic information in a single long-read sequencing assay. This first-of-its-kind technology delivers unprecedented resolution of DNA sequence and chromatin features along individual DNA molecules, opening an entirely new dimension […]
Partnership aimed at improving cell separation and increasing cell viability WILMINGTON, Mass. — Charles River Laboratories International, Inc. (NYSE: CRL) and Akadeum Life Sciences, a leader in advanced cell separation technologies, announced today the integration of Akadeum’s GMP-grade Human T Cell Leukopak Isolation Kit into Charles River’s Cell Therapy Flex Program. Charles River’s Cell Therapy Flex […]
DÜSSELDORF, Germany – LenioBio GmbH today announced a strategic partnership with AffinityAI, a Danish start-up pioneering AI-driven protein design. This collaboration combines LenioBio’s proprietary cell-free protein expression platform, ALiCE®, with AffinityAI’s advanced design engine, Designerbodies™, to significantly accelerate the discovery and optimization de novo proteins. By integrating AI-guided protein design with high-throughput cell-free expression, the partnership […]
A new Hereditary Cancer Panel will interrogate 258 genes associated with inherited cancer risk Oxford Nanopore Technologies, the company behind a new generation of molecular sensing technology based on nanopores, has launched a comprehensive Hereditary Cancer Panel (HCP), which will allow users to interrogate 258 key genes associated with inherited cancer risk. The HCP provides a simple […]
Strategic acquisition of UK genomics leader Congenica reinforces SeqOne market position and footprint – servicing over 160 labs in 30+ countries The acquisition creates the largest global ‘software pure player’ in the clinical genomics space, which will maintain UK presence at the renowned Wellcome Sanger Institute MONTPELLIER, France, and CAMBRIDGE, UK: SeqOne, a pioneer in […]
Europa Biosite is pleased to announce that Bio X Cell has appointed Cambridge Bioscience, a proud member of Europa Biosite, as its exclusive distributor for the United Kingdom and Ireland. This strategic partnership ensures that researchers across the UK and Ireland will have streamlined access to the Bio X Cell portfolio which features best-in-class functional monoclonal […]
New PhysioMimix in silico tools unlock deeper functional insights from existing assays, advancing translation of MPS data to predict human ADME behavior End-to-end support from experimental design to data interpretation Cambridge, UK — CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced the expansion of its […]
SOUTH SAN FRANCISCO, Calif. — Twist Bioscience Corporation (NASDAQ: TWST), a mid-cap growth and value biotech company, today announced that it has collaborated with next generation therapeutics company, Synthetic Design Lab (SDL). “With our high throughput expertise, from novel binder discovery services to high throughput screening capabilities, we’re able to support researchers working to unlock novel engineered therapeutics,” […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
